Health Insurance Marketplace Guide for Asthma and Allergies for 2026
The Asthma and Allergy Foundation of America (AAFA) has published a new resource: “Health Insurance
The Asthma and Allergy Foundation of America (AAFA) has published a new resource: “Health Insurance
Looking to help yourself or others quit tobacco for good? The Michigan Department of Health
Find a vaccine appointment easily. The EasyVax application is a universal vaccine scheduling application that
As anti-inflammatory rescue therapies begin making their way to patients with asthma, new questions about
About Us Committees ul > .bdt-post-list-item; delay: 350;”> Data and Publications Committee Executive Committee Patient
General Update On 07/09/2025 Teva discontinued distribution of the AirDuo® RespiClick® (fluticasone propionate and salmeterol)
In this American Medical Journal interview, Njira Lugogo, MD, Monica Kraft, MD, and Reynold A.
Introduction to INHALE Current Members ul > .bdt-post-list-item; delay: 350;”> In-Check Dial Request Meetings Member
AstraZenca is recalling more than 1 million inhalers for a defective delivery system. Recalled inhalers
The “theme” of the 2025 GINA Strategy is “Make Inhaled Treatments Accessible for ALL.” “Doctors
INHALE prepares regular PO and Clinical level newsletters that contain:
Arbor Lakes Building 3, Floor 3
4251 Plymouth Rd.
Ann Arbor, MI 48105
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.